The E. coli CNF1 as a pioneering therapy for the central nervous system diseases

Sara Travaglione1, Stefano Loizzo2, Giulia Ballan3

  • 1Department of Therapeutic Research and Medicines Evaluation, Superior Health Institute, viale Regina Elena 299, Rome 00161, Italy. sara.travaglione@iss.it.

Toxins
|January 10, 2014
PubMed